|本期目录/Table of Contents|

[1]李 苏,顾继山,吴晓宇,等.恩曲他滨的合成工艺优化[J].武汉工程大学学报,2020,42(02):129-133.[doi:10.19843/j.cnki.CN42-1779/TQ. 202002004]
 LI Su,GU Jishan,WU Xiaoyu,et al.Synthetic Procedure Optimization of Emtricitabine[J].Journal of Wuhan Institute of Technology,2020,42(02):129-133.[doi:10.19843/j.cnki.CN42-1779/TQ. 202002004]
点击复制

恩曲他滨的合成工艺优化(/HTML)
分享到:

《武汉工程大学学报》[ISSN:1674-2869/CN:42-1779/TQ]

卷:
42
期数:
2020年02期
页码:
129-133
栏目:
化学与化学工程
出版日期:
2021-01-26

文章信息/Info

Title:
Synthetic Procedure Optimization of Emtricitabine
文章编号:
1674 - 2869(2020)02 - 0129 - 05
作者:
李 苏顾继山吴晓宇熊 芸孙国锋丁一刚刘生鹏*
武汉工程大学化工与制药学院,湖北 武汉 430205
Author(s):
LI Su GU Jishan WU Xiaoyu XIONG Yun SUN Guofeng DING Yigang LIU Shengpeng*
School of Chemical Engineering and Pharmacy, Wuhan Institute of Technology, Wuhan 430205, China
关键词:
恩曲他滨脂肪酶Novozyme 435(2R 5S)-2-苯甲酰氧甲基-5-乙酰氧基-l3-氧硫杂环戊烷合成
Keywords:
emtricitabine Novozyme 435 (2R 5S)-2-benzoyloxymethyl-5-acetoxy-1 3-oxathiolane synthesis
分类号:
R978.7
DOI:
10.19843/j.cnki.CN42-1779/TQ. 202002004
文献标志码:
A
摘要:
为满足临床对HIV药物的需求,优化了HIV核苷类逆转录酶抑制剂恩曲他滨的合成工艺。以苯甲酸钠和溴乙醛缩二乙醇为原料,经五步反应,即缩合、缩醛水解、脂肪酶Novozyme 435催化环化和酰化,合成中间体(2R, 5S)-2-苯甲酰氧甲基-5-乙酰氧基-l, 3-氧硫杂环戊烷,然后将其进行偶联、水解反应得到99.7%纯度的恩曲他滨,总收率为51.3%。制备的化合物通过核磁共振氢谱(1H NMR)以及核磁共振碳谱(13C NMR)确证。与已有工艺相比,本合成工艺具有安全性好、收率高、成本低的特点,易于生产出符合原料药质量标准的产品。
Abstract:
To meet the requirements of clinical drugs of human immunodeficiency virus(HIV), the synthetic procedure of the HIV nucleoside analogue reverse transcriptase inhibitor emtricitabine was optimized. The key intermediate (2R, 5S)-2-benzoyloxymethyl-5-acetoxy-1,3-oxathiolane was synthesized from sodium benzoate and bromoacetaldehyde diethyl acetal as starting materials via five-step reactions including condensation, hydrolysis, cyclization and acylation by immobilized Candida antarctica lipase B (Novozyme 435). Then the intermediate was subjected to coupling and hydrolysis to get the target compound emtricitabine with 51.3% total yield and up to 99.7% purity. The chemical structures of compounds were confirmed by nuclear magnetic resonance spectroscopy (1H NMR and 13C NMR). Compared with the preceding process, the improved process has the characteristics of safety, higher yield and lower cost, which can meet the quality standards of active pharmaceutical ingredient.

参考文献/References:

[1] BANG L M, SCOTT L J. Emtricitabine[J]. Drugs, 2003, 63(22): 2413-2424. [2] STELLBRINK H J, LAZZARIN A, WOOLLEY I, et al. The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single‐tablet regimen in the expanding spectrum of fixed‐dose combination therapy for HIV[J]. HIV Medicine, 2020, 21(S1): 3-16. [3] WANG Y Y, CAO Y X, LI Y X, et al. Asymmetric biosynthesis of intermediates of anti-HIV drugs[J]. Tetrahedron: Asymmetry, 2017, 28: 745-757. [4] MANDALA D, WATTS P. An improved synthesis of lamivudine and emtricitabine[J]. Chemistry Select, 2017, 2(3): 1102-1105. [5] 赫畅,刘国峰,马英,等. 恩曲他滨的合成工艺研究[J]. 中国药物化学杂志,2017,27(2):117-121. [6] TYAGI O D. Process for producing 5‐fluoro‐1‐(2R,5S)‐[2‐(hydroxymethyl)‐1, 3‐oxathiolan‐5‐yl] cytosine: US, 8350030[P]. 2013-01-08. [7] 周鸣强,沈怡,吴贝,等. 恩曲他滨顺式和反式消旋体的简便合成[J]. 华西药学杂志,2007,22(1):46-48.[8] 张利刚. 1, 3‐二芳基‐4‐醛基吡唑衍生物及杂环类药物吉非替尼、拉米夫定的合成研究[D]. 吉林:吉林大学,2005. [9] 柯彩霞,徐德蛟,闫云君,等. 生物酶法拆分手性药物的研究进展[J]. 武汉工程大学学报, 2016, 38(6):517-520. [10] XING X, JIA J Q, ZHANG J F, et al. CALB immobilized onto magnetic nanoparticles for efficient kinetic resolution of racemic secondary alcohols: long-term stability and reusability[J]. Molecules, 2019, 24(3): 490-507. [11] LUND I T, B?CKMANN P L, JACOBSEN E E. Highly enantioselective CALB-catalyzed kinetic resolution of building blocks for β-blocker atenolol[J]. Tetrahedron, 2016, 72(46): 7288-7292. [12] HU L, SCHAUFELBERGER F, ZHANG Y, et al. Efficient asymmetric synthesis of lamivudine via enzymatic dynamic kinetic resolution[J]. Chemical Communication, 2013, 49(88): 10376-10378. [13] ZHANG Y Y, GAO X, WANG C, et al. One-pot stereoselective synthesis of chiral 1, 3-oxathiolane by trichosporon laibachii lipase: optimization by response surface methodology integrated a desirability function approach[J]. Journal of Molecular Catalysis B Enzymatic, 2016, 133:27-34. [14] YUAN X, ZHANG P, XU W F, et al. Kinetic study on enantioselective resolution of (R, S)-2 - phenylpropionic acid through Novozyme 435-catalyzed esterification[J]. International Journal of Chemical Kinetics, 2019, 51(7): 520-527. [15] HU L, REN Y S, RAMSTROM O. Chirality control in enzyme-catalyzed dynamic kinetic resolution of 1, 3-oxathiolanes[J]. The Journal of Organic Chemistry, 2015, 80(16): 8478-8481.

相似文献/References:

备注/Memo

备注/Memo:
收稿日期:2020-02-05基金项目:湖北省技术创新专项重大项目(2017ACA086)作者简介:李 苏,硕士研究生。E-mail:15183955902@163.com*通讯作者:刘生鹏,博士,教授,博士生导师。E-mail:liuabss@163.com引文格式:李苏,顾继山,吴晓宇,等. 恩曲他滨的合成工艺优化[J]. 武汉工程大学学报,2020,42(2):129-133.
更新日期/Last Update: 2020-06-19